-
Sat22Feb2020Tue25Feb2020
-
Fri28Feb2020Sun01Mar2020
-
Wed17Jun2020Sat20Jun2020
-
Wed23Sep2020Sun27Sep2020
Latest News
Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results
George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial session at the American Heart Association Scientific Sessions (AHA 2019;...
Features
BIBA Briefings: Longest and largest follow-up data for Watchman supports its...
Data from the CAP and CAP2 registries—which contain the longest and largest follow-up of patients—add to previous evidence that left atrial appendage closure (LAAC)...
Further innovation and research is required for thrombus aspiration in PCI
The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing percutaneous coronary intervention (PCI) did not provide mortality benefit and may...
Videos
Michael Reardon (Houston, USA) talks to BLearning Cardio about the ADAPT tissue technology (Admedus), and the increasing importance of durability as TAVI moves to younger and lower risk patients.
Reardon notes that “we would like to have technology that does even better...
